AbbVie (ABBV) Current Deferred Tax Assets (2012 - 2015)

AbbVie (ABBV) has 4 years of Current Deferred Tax Assets data on file, last reported at $1.1 billion in Q3 2015.

• Quarterly Current Deferred Tax Assets rose 109.92% year-over-year to $1.1 billion in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $1.1 billion (up 109.92% YoY) and the FY2014 annual result came in at $896.0 million, up 16.97% from the prior year.
• Current Deferred Tax Assets fell to $1.1 billion in Q3 2015 per ABBV's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $1.4 billion in Q2 2013 and bottomed at $524.0 million in Q3 2014.
• The 4-year median for Current Deferred Tax Assets is $1.1 billion (2014), against an average of $1.1 billion.
• The widest annual swing landed in 2014, when Current Deferred Tax Assets plunged 63.07%; it then jumped 109.92% in 2015.
• Tracing ABBV's Current Deferred Tax Assets over 4 years: stood at $669.0 million in 2012, then climbed by 14.5% to $766.0 million in 2013, then advanced by 16.97% to $896.0 million in 2014, then grew by 22.77% to $1.1 billion in 2015.
• Per Business Quant, the three latest ABBV Current Deferred Tax Assets figures stand at $1.1 billion (Q3 2015), $1.2 billion (Q2 2015), and $1.1 billion (Q1 2015).

Peer Comparison